Product Details for ANDA 062564
KANTREX (KANAMYCIN SULFATE)
EQ 75MG BASE/2ML
Marketing Status: Discontinued
EQ 500MG BASE/2ML
Marketing Status: Discontinued
EQ 1GM BASE/3ML
Marketing Status: Discontinued
EQ 75MG BASE/2ML
Marketing Status: Discontinued
Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 75MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 001
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
KANTREX (KANAMYCIN SULFATE)
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 75MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 001
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 500MG BASE/2ML
Marketing Status: Discontinued
Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 002
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
KANTREX (KANAMYCIN SULFATE)
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 002
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 1GM BASE/3ML
Marketing Status: Discontinued
Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/3ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 003
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: KANTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/3ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062564
Product Number: 003
Approval Date: Sep 21, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information